Phenazop

Article Contents ::

Details About Generic Salt ::  Phenazop

Main Medicine Class:: Urinary tract product,Analgesic   

(fen-AZZ-oh-PIH-rih-deen HIGH-droe-KLOR-ide)
Azo-Standard, Baridium, Geridium, Prodium, Pyridiate, Pyridium, Pyridium Plus, Urodine, Urogesic, UTI Relief,  Phenazo, Pyronium, Vitoreins
Class: Urinary tract product/Analgesic

 

Action Exerts topical analgesic effect on urinary tract mucosa.

 

Indications Symptomatic relief of pain, burning, urgency, frequency and other discomforts arising from irritation of lower urinary tract mucosa.

 

Contraindications Renal insufficiency.

 

Route/Dosage

ADULTS: PO 200 mg tid. CHILDREN (6 to 12 YR): PO 12 mg/kg/24 hr divided into three doses for 2 days.

 

Interactions None well documented.

 

Lab Test Interferences Possible interference with colorimetric lab test procedures and urinalysis based on spectrometry or color reactions.

 

Adverse Reactions

CNS: Headache. DERM: Rash; pruritus. GI: Occasional GI disturbances. GU: Renal toxicity. HEMA: Methemoglobinemia; hemolytic anemia. HEPA: Hepatotoxicity. OTHER: Anaphylactoid reaction.

 

Precautions

Pregnancy: Category B. Lactation: Unknown. Renal impairment: May lead to accumulation, indicated by yellow tinge to skin and sclera.

PATIENT CARE CONSIDERATIONS

 

Administration/Storage

  • Administer after meals to avoid GI irritation.
  • If patient has renal impairment, dosage reduction may be required.
  • If being taken concomitantly with antibiotics for urinary tract infection, this medicine should be taken for only 2 days (6 doses).
  • Do not crush tablets or make into a suspension.
  • Store at room temperature in a tightly closed container.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Obtain BUN and creatinine to assess for renal dysfunction.
OVERDOSAGE: SIGNS & SYMPTOMS
  Methemoglobinemia, hemolytic anemia, hemolysis, renal and hepatic impairment and failure

 

Patient/Family Education

  • Inform patient that this drug should not be taken long term for undiagnosed urinary tract pain.
  • Advise patient to take drug after meals to avoid GI upset.
  • Inform patient that urine may temporarily become reddish-orange in color and may stain fabric.
  • Advise patient to wear glasses instead of contact lenses while taking this drug; contact lenses may become discolored.
  • Inform patients with diabetes of possible interference with urine glucose test results.
  • Instruct patient not to crush or chew tablets. Permanent teeth discoloration may occur.
  • Instruct patient that if skin or sclera become yellowish in color, to discontinue drug and notify physician.
  • Instruct patient to notify physician if headache, rash, pruritus, upset stomach, dizziness or difficulty breathing occurs.

 

Drugs Class ::

(fen-AZZ-oh-PIH-rih-deen HIGH-droe-KLOR-ide)
Azo-Standard, Baridium, Geridium, Prodium, Pyridiate, Pyridium, Pyridium Plus, Urodine, Urogesic, UTI Relief,  Phenazo, Pyronium, Vitoreins
Class: Urinary tract product/Analgesic

 

Action Exerts topical analgesic effect on urinary tract mucosa.

 

Indications Symptomatic relief of pain, burning, urgency, frequency and other discomforts arising from irritation of lower urinary tract mucosa.

 

Contraindications Renal insufficiency.

 

Route/Dosage

ADULTS: PO 200 mg tid. CHILDREN (6 to 12 YR): PO 12 mg/kg/24 hr divided into three doses for 2 days.

 

Interactions None well documented.

 

Lab Test Interferences Possible interference with colorimetric lab test procedures and urinalysis based on spectrometry or color reactions.

 

Adverse Reactions

CNS: Headache. DERM: Rash; pruritus. GI: Occasional GI disturbances. GU: Renal toxicity. HEMA: Methemoglobinemia; hemolytic anemia. HEPA: Hepatotoxicity. OTHER: Anaphylactoid reaction.

 

Precautions

Pregnancy: Category B. Lactation: Unknown. Renal impairment: May lead to accumulation, indicated by yellow tinge to skin and sclera.

PATIENT CARE CONSIDERATIONS

 

Administration/Storage

  • Administer after meals to avoid GI irritation.
  • If patient has renal impairment, dosage reduction may be required.
  • If being taken concomitantly with antibiotics for urinary tract infection, this medicine should be taken for only 2 days (6 doses).
  • Do not crush tablets or make into a suspension.
  • Store at room temperature in a tightly closed container.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Obtain BUN and creatinine to assess for renal dysfunction.
OVERDOSAGE: SIGNS & SYMPTOMS
  Methemoglobinemia, hemolytic anemia, hemolysis, renal and hepatic impairment and failure

 

Patient/Family Education

  • Inform patient that this drug should not be taken long term for undiagnosed urinary tract pain.
  • Advise patient to take drug after meals to avoid GI upset.
  • Inform patient that urine may temporarily become reddish-orange in color and may stain fabric.
  • Advise patient to wear glasses instead of contact lenses while taking this drug; contact lenses may become discolored.
  • Inform patients with diabetes of possible interference with urine glucose test results.
  • Instruct patient not to crush or chew tablets. Permanent teeth discoloration may occur.
  • Instruct patient that if skin or sclera become yellowish in color, to discontinue drug and notify physician.
  • Instruct patient to notify physician if headache, rash, pruritus, upset stomach, dizziness or difficulty breathing occurs.

Indications for Drugs ::

(fen-AZZ-oh-PIH-rih-deen HIGH-droe-KLOR-ide)
Azo-Standard, Baridium, Geridium, Prodium, Pyridiate, Pyridium, Pyridium Plus, Urodine, Urogesic, UTI Relief,  Phenazo, Pyronium, Vitoreins
Class: Urinary tract product/Analgesic

 

Action Exerts topical analgesic effect on urinary tract mucosa.

 

Indications Symptomatic relief of pain, burning, urgency, frequency and other discomforts arising from irritation of lower urinary tract mucosa.

 

Contraindications Renal insufficiency.

 

Route/Dosage

ADULTS: PO 200 mg tid. CHILDREN (6 to 12 YR): PO 12 mg/kg/24 hr divided into three doses for 2 days.

 

Interactions None well documented.

 

Lab Test Interferences Possible interference with colorimetric lab test procedures and urinalysis based on spectrometry or color reactions.

 

Adverse Reactions

CNS: Headache. DERM: Rash; pruritus. GI: Occasional GI disturbances. GU: Renal toxicity. HEMA: Methemoglobinemia; hemolytic anemia. HEPA: Hepatotoxicity. OTHER: Anaphylactoid reaction.

 

Precautions

Pregnancy: Category B. Lactation: Unknown. Renal impairment: May lead to accumulation, indicated by yellow tinge to skin and sclera.

PATIENT CARE CONSIDERATIONS

 

Administration/Storage

  • Administer after meals to avoid GI irritation.
  • If patient has renal impairment, dosage reduction may be required.
  • If being taken concomitantly with antibiotics for urinary tract infection, this medicine should be taken for only 2 days (6 doses).
  • Do not crush tablets or make into a suspension.
  • Store at room temperature in a tightly closed container.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Obtain BUN and creatinine to assess for renal dysfunction.
OVERDOSAGE: SIGNS & SYMPTOMS
  Methemoglobinemia, hemolytic anemia, hemolysis, renal and hepatic impairment and failure

 

Patient/Family Education

  • Inform patient that this drug should not be taken long term for undiagnosed urinary tract pain.
  • Advise patient to take drug after meals to avoid GI upset.
  • Inform patient that urine may temporarily become reddish-orange in color and may stain fabric.
  • Advise patient to wear glasses instead of contact lenses while taking this drug; contact lenses may become discolored.
  • Inform patients with diabetes of possible interference with urine glucose test results.
  • Instruct patient not to crush or chew tablets. Permanent teeth discoloration may occur.
  • Instruct patient that if skin or sclera become yellowish in color, to discontinue drug and notify physician.
  • Instruct patient to notify physician if headache, rash, pruritus, upset stomach, dizziness or difficulty breathing occurs.

Drug Dose ::

(fen-AZZ-oh-PIH-rih-deen HIGH-droe-KLOR-ide)
Azo-Standard, Baridium, Geridium, Prodium, Pyridiate, Pyridium, Pyridium Plus, Urodine, Urogesic, UTI Relief,  Phenazo, Pyronium, Vitoreins
Class: Urinary tract product/Analgesic

 

Action Exerts topical analgesic effect on urinary tract mucosa.

 

Indications Symptomatic relief of pain, burning, urgency, frequency and other discomforts arising from irritation of lower urinary tract mucosa.

 

Contraindications Renal insufficiency.

 

Route/Dosage

ADULTS: PO 200 mg tid. CHILDREN (6 to 12 YR): PO 12 mg/kg/24 hr divided into three doses for 2 days.

 

Interactions None well documented.

 

Lab Test Interferences Possible interference with colorimetric lab test procedures and urinalysis based on spectrometry or color reactions.

 

Adverse Reactions

CNS: Headache. DERM: Rash; pruritus. GI: Occasional GI disturbances. GU: Renal toxicity. HEMA: Methemoglobinemia; hemolytic anemia. HEPA: Hepatotoxicity. OTHER: Anaphylactoid reaction.

 

Precautions

Pregnancy: Category B. Lactation: Unknown. Renal impairment: May lead to accumulation, indicated by yellow tinge to skin and sclera.

PATIENT CARE CONSIDERATIONS

 

Administration/Storage

  • Administer after meals to avoid GI irritation.
  • If patient has renal impairment, dosage reduction may be required.
  • If being taken concomitantly with antibiotics for urinary tract infection, this medicine should be taken for only 2 days (6 doses).
  • Do not crush tablets or make into a suspension.
  • Store at room temperature in a tightly closed container.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Obtain BUN and creatinine to assess for renal dysfunction.
OVERDOSAGE: SIGNS & SYMPTOMS
  Methemoglobinemia, hemolytic anemia, hemolysis, renal and hepatic impairment and failure

 

Patient/Family Education

  • Inform patient that this drug should not be taken long term for undiagnosed urinary tract pain.
  • Advise patient to take drug after meals to avoid GI upset.
  • Inform patient that urine may temporarily become reddish-orange in color and may stain fabric.
  • Advise patient to wear glasses instead of contact lenses while taking this drug; contact lenses may become discolored.
  • Inform patients with diabetes of possible interference with urine glucose test results.
  • Instruct patient not to crush or chew tablets. Permanent teeth discoloration may occur.
  • Instruct patient that if skin or sclera become yellowish in color, to discontinue drug and notify physician.
  • Instruct patient to notify physician if headache, rash, pruritus, upset stomach, dizziness or difficulty breathing occurs.

Contraindication ::

(fen-AZZ-oh-PIH-rih-deen HIGH-droe-KLOR-ide)
Azo-Standard, Baridium, Geridium, Prodium, Pyridiate, Pyridium, Pyridium Plus, Urodine, Urogesic, UTI Relief,  Phenazo, Pyronium, Vitoreins
Class: Urinary tract product/Analgesic

 

Action Exerts topical analgesic effect on urinary tract mucosa.

 

Indications Symptomatic relief of pain, burning, urgency, frequency and other discomforts arising from irritation of lower urinary tract mucosa.

 

Contraindications Renal insufficiency.

 

Route/Dosage

ADULTS: PO 200 mg tid. CHILDREN (6 to 12 YR): PO 12 mg/kg/24 hr divided into three doses for 2 days.

 

Interactions None well documented.

 

Lab Test Interferences Possible interference with colorimetric lab test procedures and urinalysis based on spectrometry or color reactions.

 

Adverse Reactions

CNS: Headache. DERM: Rash; pruritus. GI: Occasional GI disturbances. GU: Renal toxicity. HEMA: Methemoglobinemia; hemolytic anemia. HEPA: Hepatotoxicity. OTHER: Anaphylactoid reaction.

 

Precautions

Pregnancy: Category B. Lactation: Unknown. Renal impairment: May lead to accumulation, indicated by yellow tinge to skin and sclera.

PATIENT CARE CONSIDERATIONS

 

Administration/Storage

  • Administer after meals to avoid GI irritation.
  • If patient has renal impairment, dosage reduction may be required.
  • If being taken concomitantly with antibiotics for urinary tract infection, this medicine should be taken for only 2 days (6 doses).
  • Do not crush tablets or make into a suspension.
  • Store at room temperature in a tightly closed container.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Obtain BUN and creatinine to assess for renal dysfunction.
OVERDOSAGE: SIGNS & SYMPTOMS
  Methemoglobinemia, hemolytic anemia, hemolysis, renal and hepatic impairment and failure

 

Patient/Family Education

  • Inform patient that this drug should not be taken long term for undiagnosed urinary tract pain.
  • Advise patient to take drug after meals to avoid GI upset.
  • Inform patient that urine may temporarily become reddish-orange in color and may stain fabric.
  • Advise patient to wear glasses instead of contact lenses while taking this drug; contact lenses may become discolored.
  • Inform patients with diabetes of possible interference with urine glucose test results.
  • Instruct patient not to crush or chew tablets. Permanent teeth discoloration may occur.
  • Instruct patient that if skin or sclera become yellowish in color, to discontinue drug and notify physician.
  • Instruct patient to notify physician if headache, rash, pruritus, upset stomach, dizziness or difficulty breathing occurs.

Drug Precautions ::

(fen-AZZ-oh-PIH-rih-deen HIGH-droe-KLOR-ide)
Azo-Standard, Baridium, Geridium, Prodium, Pyridiate, Pyridium, Pyridium Plus, Urodine, Urogesic, UTI Relief,  Phenazo, Pyronium, Vitoreins
Class: Urinary tract product/Analgesic

 

Action Exerts topical analgesic effect on urinary tract mucosa.

 

Indications Symptomatic relief of pain, burning, urgency, frequency and other discomforts arising from irritation of lower urinary tract mucosa.

 

Contraindications Renal insufficiency.

 

Route/Dosage

ADULTS: PO 200 mg tid. CHILDREN (6 to 12 YR): PO 12 mg/kg/24 hr divided into three doses for 2 days.

 

Interactions None well documented.

 

Lab Test Interferences Possible interference with colorimetric lab test procedures and urinalysis based on spectrometry or color reactions.

 

Adverse Reactions

CNS: Headache. DERM: Rash; pruritus. GI: Occasional GI disturbances. GU: Renal toxicity. HEMA: Methemoglobinemia; hemolytic anemia. HEPA: Hepatotoxicity. OTHER: Anaphylactoid reaction.

 

Precautions

Pregnancy: Category B. Lactation: Unknown. Renal impairment: May lead to accumulation, indicated by yellow tinge to skin and sclera.

PATIENT CARE CONSIDERATIONS

 

Administration/Storage

  • Administer after meals to avoid GI irritation.
  • If patient has renal impairment, dosage reduction may be required.
  • If being taken concomitantly with antibiotics for urinary tract infection, this medicine should be taken for only 2 days (6 doses).
  • Do not crush tablets or make into a suspension.
  • Store at room temperature in a tightly closed container.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Obtain BUN and creatinine to assess for renal dysfunction.
OVERDOSAGE: SIGNS & SYMPTOMS
  Methemoglobinemia, hemolytic anemia, hemolysis, renal and hepatic impairment and failure

 

Patient/Family Education

  • Inform patient that this drug should not be taken long term for undiagnosed urinary tract pain.
  • Advise patient to take drug after meals to avoid GI upset.
  • Inform patient that urine may temporarily become reddish-orange in color and may stain fabric.
  • Advise patient to wear glasses instead of contact lenses while taking this drug; contact lenses may become discolored.
  • Inform patients with diabetes of possible interference with urine glucose test results.
  • Instruct patient not to crush or chew tablets. Permanent teeth discoloration may occur.
  • Instruct patient that if skin or sclera become yellowish in color, to discontinue drug and notify physician.
  • Instruct patient to notify physician if headache, rash, pruritus, upset stomach, dizziness or difficulty breathing occurs.

Drug Side Effects ::

(fen-AZZ-oh-PIH-rih-deen HIGH-droe-KLOR-ide)
Azo-Standard, Baridium, Geridium, Prodium, Pyridiate, Pyridium, Pyridium Plus, Urodine, Urogesic, UTI Relief,  Phenazo, Pyronium, Vitoreins
Class: Urinary tract product/Analgesic

 

Action Exerts topical analgesic effect on urinary tract mucosa.

 

Indications Symptomatic relief of pain, burning, urgency, frequency and other discomforts arising from irritation of lower urinary tract mucosa.

 

Contraindications Renal insufficiency.

 

Route/Dosage

ADULTS: PO 200 mg tid. CHILDREN (6 to 12 YR): PO 12 mg/kg/24 hr divided into three doses for 2 days.

 

Interactions None well documented.

 

Lab Test Interferences Possible interference with colorimetric lab test procedures and urinalysis based on spectrometry or color reactions.

 

Adverse Reactions

CNS: Headache. DERM: Rash; pruritus. GI: Occasional GI disturbances. GU: Renal toxicity. HEMA: Methemoglobinemia; hemolytic anemia. HEPA: Hepatotoxicity. OTHER: Anaphylactoid reaction.

 

Precautions

Pregnancy: Category B. Lactation: Unknown. Renal impairment: May lead to accumulation, indicated by yellow tinge to skin and sclera.

PATIENT CARE CONSIDERATIONS

 

Administration/Storage

  • Administer after meals to avoid GI irritation.
  • If patient has renal impairment, dosage reduction may be required.
  • If being taken concomitantly with antibiotics for urinary tract infection, this medicine should be taken for only 2 days (6 doses).
  • Do not crush tablets or make into a suspension.
  • Store at room temperature in a tightly closed container.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Obtain BUN and creatinine to assess for renal dysfunction.
OVERDOSAGE: SIGNS & SYMPTOMS
  Methemoglobinemia, hemolytic anemia, hemolysis, renal and hepatic impairment and failure

 

Patient/Family Education

  • Inform patient that this drug should not be taken long term for undiagnosed urinary tract pain.
  • Advise patient to take drug after meals to avoid GI upset.
  • Inform patient that urine may temporarily become reddish-orange in color and may stain fabric.
  • Advise patient to wear glasses instead of contact lenses while taking this drug; contact lenses may become discolored.
  • Inform patients with diabetes of possible interference with urine glucose test results.
  • Instruct patient not to crush or chew tablets. Permanent teeth discoloration may occur.
  • Instruct patient that if skin or sclera become yellowish in color, to discontinue drug and notify physician.
  • Instruct patient to notify physician if headache, rash, pruritus, upset stomach, dizziness or difficulty breathing occurs.

Drug Mode of Action ::  

(fen-AZZ-oh-PIH-rih-deen HIGH-droe-KLOR-ide)
Azo-Standard, Baridium, Geridium, Prodium, Pyridiate, Pyridium, Pyridium Plus, Urodine, Urogesic, UTI Relief,  Phenazo, Pyronium, Vitoreins
Class: Urinary tract product/Analgesic

 

Action Exerts topical analgesic effect on urinary tract mucosa.

 

Indications Symptomatic relief of pain, burning, urgency, frequency and other discomforts arising from irritation of lower urinary tract mucosa.

 

Contraindications Renal insufficiency.

 

Route/Dosage

ADULTS: PO 200 mg tid. CHILDREN (6 to 12 YR): PO 12 mg/kg/24 hr divided into three doses for 2 days.

 

Interactions None well documented.

 

Lab Test Interferences Possible interference with colorimetric lab test procedures and urinalysis based on spectrometry or color reactions.

 

Adverse Reactions

CNS: Headache. DERM: Rash; pruritus. GI: Occasional GI disturbances. GU: Renal toxicity. HEMA: Methemoglobinemia; hemolytic anemia. HEPA: Hepatotoxicity. OTHER: Anaphylactoid reaction.

 

Precautions

Pregnancy: Category B. Lactation: Unknown. Renal impairment: May lead to accumulation, indicated by yellow tinge to skin and sclera.

PATIENT CARE CONSIDERATIONS

 

Administration/Storage

  • Administer after meals to avoid GI irritation.
  • If patient has renal impairment, dosage reduction may be required.
  • If being taken concomitantly with antibiotics for urinary tract infection, this medicine should be taken for only 2 days (6 doses).
  • Do not crush tablets or make into a suspension.
  • Store at room temperature in a tightly closed container.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Obtain BUN and creatinine to assess for renal dysfunction.
OVERDOSAGE: SIGNS & SYMPTOMS
  Methemoglobinemia, hemolytic anemia, hemolysis, renal and hepatic impairment and failure

 

Patient/Family Education

  • Inform patient that this drug should not be taken long term for undiagnosed urinary tract pain.
  • Advise patient to take drug after meals to avoid GI upset.
  • Inform patient that urine may temporarily become reddish-orange in color and may stain fabric.
  • Advise patient to wear glasses instead of contact lenses while taking this drug; contact lenses may become discolored.
  • Inform patients with diabetes of possible interference with urine glucose test results.
  • Instruct patient not to crush or chew tablets. Permanent teeth discoloration may occur.
  • Instruct patient that if skin or sclera become yellowish in color, to discontinue drug and notify physician.
  • Instruct patient to notify physician if headache, rash, pruritus, upset stomach, dizziness or difficulty breathing occurs.

Drug Interactions ::

(fen-AZZ-oh-PIH-rih-deen HIGH-droe-KLOR-ide)
Azo-Standard, Baridium, Geridium, Prodium, Pyridiate, Pyridium, Pyridium Plus, Urodine, Urogesic, UTI Relief,  Phenazo, Pyronium, Vitoreins
Class: Urinary tract product/Analgesic

 

Action Exerts topical analgesic effect on urinary tract mucosa.

 

Indications Symptomatic relief of pain, burning, urgency, frequency and other discomforts arising from irritation of lower urinary tract mucosa.

 

Contraindications Renal insufficiency.

 

Route/Dosage

ADULTS: PO 200 mg tid. CHILDREN (6 to 12 YR): PO 12 mg/kg/24 hr divided into three doses for 2 days.

 

Interactions None well documented.

 

Drug Assesment ::

(fen-AZZ-oh-PIH-rih-deen HIGH-droe-KLOR-ide)
Azo-Standard, Baridium, Geridium, Prodium, Pyridiate, Pyridium, Pyridium Plus, Urodine, Urogesic, UTI Relief,  Phenazo, Pyronium, Vitoreins
Class: Urinary tract product/Analgesic

 

Action Exerts topical analgesic effect on urinary tract mucosa.

 

Indications Symptomatic relief of pain, burning, urgency, frequency and other discomforts arising from irritation of lower urinary tract mucosa.

 

Contraindications Renal insufficiency.

 

Route/Dosage

ADULTS: PO 200 mg tid. CHILDREN (6 to 12 YR): PO 12 mg/kg/24 hr divided into three doses for 2 days.

 

Interactions None well documented.

 

Lab Test Interferences Possible interference with colorimetric lab test procedures and urinalysis based on spectrometry or color reactions.

 

Adverse Reactions

CNS: Headache. DERM: Rash; pruritus. GI: Occasional GI disturbances. GU: Renal toxicity. HEMA: Methemoglobinemia; hemolytic anemia. HEPA: Hepatotoxicity. OTHER: Anaphylactoid reaction.

 

Precautions

Pregnancy: Category B. Lactation: Unknown. Renal impairment: May lead to accumulation, indicated by yellow tinge to skin and sclera.

PATIENT CARE CONSIDERATIONS

 

Administration/Storage

  • Administer after meals to avoid GI irritation.
  • If patient has renal impairment, dosage reduction may be required.
  • If being taken concomitantly with antibiotics for urinary tract infection, this medicine should be taken for only 2 days (6 doses).
  • Do not crush tablets or make into a suspension.
  • Store at room temperature in a tightly closed container.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Obtain BUN and creatinine to assess for renal dysfunction.
OVERDOSAGE: SIGNS & SYMPTOMS
  Methemoglobinemia, hemolytic anemia, hemolysis, renal and hepatic impairment and failure

 

Patient/Family Education

  • Inform patient that this drug should not be taken long term for undiagnosed urinary tract pain.
  • Advise patient to take drug after meals to avoid GI upset.
  • Inform patient that urine may temporarily become reddish-orange in color and may stain fabric.
  • Advise patient to wear glasses instead of contact lenses while taking this drug; contact lenses may become discolored.
  • Inform patients with diabetes of possible interference with urine glucose test results.
  • Instruct patient not to crush or chew tablets. Permanent teeth discoloration may occur.
  • Instruct patient that if skin or sclera become yellowish in color, to discontinue drug and notify physician.
  • Instruct patient to notify physician if headache, rash, pruritus, upset stomach, dizziness or difficulty breathing occurs.

Drug Storage/Management ::

(fen-AZZ-oh-PIH-rih-deen HIGH-droe-KLOR-ide)
Azo-Standard, Baridium, Geridium, Prodium, Pyridiate, Pyridium, Pyridium Plus, Urodine, Urogesic, UTI Relief,  Phenazo, Pyronium, Vitoreins
Class: Urinary tract product/Analgesic

 

Action Exerts topical analgesic effect on urinary tract mucosa.

 

Indications Symptomatic relief of pain, burning, urgency, frequency and other discomforts arising from irritation of lower urinary tract mucosa.

 

Contraindications Renal insufficiency.

 

Route/Dosage

ADULTS: PO 200 mg tid. CHILDREN (6 to 12 YR): PO 12 mg/kg/24 hr divided into three doses for 2 days.

 

Interactions None well documented.

 

Lab Test Interferences Possible interference with colorimetric lab test procedures and urinalysis based on spectrometry or color reactions.

 

Adverse Reactions

CNS: Headache. DERM: Rash; pruritus. GI: Occasional GI disturbances. GU: Renal toxicity. HEMA: Methemoglobinemia; hemolytic anemia. HEPA: Hepatotoxicity. OTHER: Anaphylactoid reaction.

 

Precautions

Pregnancy: Category B. Lactation: Unknown. Renal impairment: May lead to accumulation, indicated by yellow tinge to skin and sclera.

PATIENT CARE CONSIDERATIONS

 

Administration/Storage

  • Administer after meals to avoid GI irritation.
  • If patient has renal impairment, dosage reduction may be required.
  • If being taken concomitantly with antibiotics for urinary tract infection, this medicine should be taken for only 2 days (6 doses).
  • Do not crush tablets or make into a suspension.
  • Store at room temperature in a tightly closed container.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Obtain BUN and creatinine to assess for renal dysfunction.
OVERDOSAGE: SIGNS & SYMPTOMS
  Methemoglobinemia, hemolytic anemia, hemolysis, renal and hepatic impairment and failure

 

Patient/Family Education

  • Inform patient that this drug should not be taken long term for undiagnosed urinary tract pain.
  • Advise patient to take drug after meals to avoid GI upset.
  • Inform patient that urine may temporarily become reddish-orange in color and may stain fabric.
  • Advise patient to wear glasses instead of contact lenses while taking this drug; contact lenses may become discolored.
  • Inform patients with diabetes of possible interference with urine glucose test results.
  • Instruct patient not to crush or chew tablets. Permanent teeth discoloration may occur.
  • Instruct patient that if skin or sclera become yellowish in color, to discontinue drug and notify physician.
  • Instruct patient to notify physician if headache, rash, pruritus, upset stomach, dizziness or difficulty breathing occurs.

Drug Notes ::

(fen-AZZ-oh-PIH-rih-deen HIGH-droe-KLOR-ide)
Azo-Standard, Baridium, Geridium, Prodium, Pyridiate, Pyridium, Pyridium Plus, Urodine, Urogesic, UTI Relief,  Phenazo, Pyronium, Vitoreins
Class: Urinary tract product/Analgesic

 

Action Exerts topical analgesic effect on urinary tract mucosa.

 

Indications Symptomatic relief of pain, burning, urgency, frequency and other discomforts arising from irritation of lower urinary tract mucosa.

 

Contraindications Renal insufficiency.

 

Route/Dosage

ADULTS: PO 200 mg tid. CHILDREN (6 to 12 YR): PO 12 mg/kg/24 hr divided into three doses for 2 days.

 

Interactions None well documented.

 

Lab Test Interferences Possible interference with colorimetric lab test procedures and urinalysis based on spectrometry or color reactions.

 

Adverse Reactions

CNS: Headache. DERM: Rash; pruritus. GI: Occasional GI disturbances. GU: Renal toxicity. HEMA: Methemoglobinemia; hemolytic anemia. HEPA: Hepatotoxicity. OTHER: Anaphylactoid reaction.

 

Precautions

Pregnancy: Category B. Lactation: Unknown. Renal impairment: May lead to accumulation, indicated by yellow tinge to skin and sclera.

PATIENT CARE CONSIDERATIONS

 

Administration/Storage

  • Administer after meals to avoid GI irritation.
  • If patient has renal impairment, dosage reduction may be required.
  • If being taken concomitantly with antibiotics for urinary tract infection, this medicine should be taken for only 2 days (6 doses).
  • Do not crush tablets or make into a suspension.
  • Store at room temperature in a tightly closed container.

 

Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Obtain BUN and creatinine to assess for renal dysfunction.
OVERDOSAGE: SIGNS & SYMPTOMS
  Methemoglobinemia, hemolytic anemia, hemolysis, renal and hepatic impairment and failure

 

Patient/Family Education

  • Inform patient that this drug should not be taken long term for undiagnosed urinary tract pain.
  • Advise patient to take drug after meals to avoid GI upset.
  • Inform patient that urine may temporarily become reddish-orange in color and may stain fabric.
  • Advise patient to wear glasses instead of contact lenses while taking this drug; contact lenses may become discolored.
  • Inform patients with diabetes of possible interference with urine glucose test results.
  • Instruct patient not to crush or chew tablets. Permanent teeth discoloration may occur.
  • Instruct patient that if skin or sclera become yellowish in color, to discontinue drug and notify physician.
  • Instruct patient to notify physician if headache, rash, pruritus, upset stomach, dizziness or difficulty breathing occurs.

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Therapeutic Division & Details ::
Analgesic
Urinary tract product
Medicine Content or Salt & Details ::
ANALGESIC
Urinary tract product

Submit a Comment

Your email address will not be published. Required fields are marked *

DOWNLOAD OUR ANDROID APP

One of the 1st in India.High Quality Generic Medicine Portal Android Application for Online Oreder & Information.

For More Join Our Membership and Get Additional 25% off on Meds, also get MLM Benefits to get a permanent earning source.

Join Membership How to Search Medicine
Android App

We would like to keep you updated with special notifications.

I accept I decline